TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview Sangamo BioSciences, Inc. - Product Pipeline Review 6 , p o ides a o e ie of the Sangamo BioSciences, I . s pha a euti al esea h a d de elop e t fo us. The report provides comprehensive information on the therapeutics under development by Sangamo BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Read More At: http://www.researchbeam.com/sangamo-biosciences-inc-product-pipeline-review-2016market
Report Overview Scope -The report provides a snapshot of the pipeline therapeutic landscape of Sangamo BioSciences, Inc. - The report provides overview of Sangamo BioSciences, Inc. including its business description, key facts, and locations and subsidiaries - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
Reasons to buy -Evaluate Sangamo BioSciences, I . s st ategi positio ith total a ess to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Identify potential new clients or partners in the target demographic - Plan mergers and a uisitio s effe ti ely y ide tifyi g key playe s a d it s ost p o isi g pipeli e the apeuti s Read More At: http://www.researchbeam.com/sangamo-biosciences-inc-product-pipeline-review-2016market
Table of Content List of Tables Sangamo BioSciences, Inc., Key Information 6 Sangamo BioSciences, Inc., Key Facts 6 Sangamo BioSciences, Inc. - Pipeline by Indication, 2016 8 Sangamo BioSciences, Inc. - Pipeline by Stage of Development, 2016 10 Sangamo BioSciences, Inc. - Monotherapy Products in Pipeline, 2016 11 Sangamo BioSciences, Inc. - Phase II, 2016 12 Sangamo BioSciences, Inc. - Phase I, 2016 13 Sangamo BioSciences, Inc. - IND/CTA Filed, 2016 14 Sangamo BioSciences, Inc. - Preclinical, 2016 15 Sangamo BioSciences, Inc. - Discovery, 2016 16 Sangamo BioSciences, Inc. - Pipeline by Target, 2016 34 Sangamo BioSciences, Inc. - Pipeline by Route of Administration, 2016 35 Sangamo BioSciences, Inc. - Pipeline by Molecule Type, 2016 36 Sangamo BioSciences, Inc. - Pipeline Products by Mechanism of Action, 2016 37 Sangamo BioSciences, Inc. - Recent Pipeline Updates, 2016 38 Sangamo BioSciences, Inc. - Discontinued Pipeline Products, 2016 50 Sangamo BioSciences, Inc., Subsidiaries 53 Read More At: http://www.researchbeam.com/sangamo-biosciences-inc-product-pipeline-review-2016market
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/sangamo-biosciences-inc-productpipeline-review-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States